Efficacy of hepatitis B vaccine in those who lost hepatitis B surface antigen during follow-up

Hepatitis Monthly

Volumn 11, Issue 2, 2011, Pages 119-122

  Taheri, Hassan ^a   Roushan, Mohammad Reza Hasanjani ^a   Amiri, Mohammad Jafar Soleimani ^b   Pouralijan, Mohammad ^b   Bijani, Ali ^a  

^a BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Razi Laboratory Medical Center   (Iran)

Author keywords

Chronic hepatitis B; Follow up study; HBsAg; Hepatitis B vaccine; Hepatitis B virus

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE; VIRUS DNA;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; SEROCONVERSION; SEX RATIO; TREATMENT OUTCOME; TREATMENT RESPONSE; VACCINATION;

EID: 79952465259     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Mahoney FJ. Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev. 1999;12(2):351-366.
2. Koziel MJ, Siddiqui A. Hepatitis B virus and hepatitis B virus. In: Mandell GL, Bennett JE, Dolin E, editors. Principles and Practice of Infectious diseases. Philadelphia: Churchill Livingstone; 2005. p. 1864-1890.
3. McMahon BJ, Holck P, Bulkow L, Snowball M. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med. 2001;135(9):759-768.
4. Brechot C, Degos F, Lugassy C, Thiers V, Zafrani S, Franco D, et al. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med. 1985;312(5):270-276.
5. Altindis M, Uslan I, Cetinkaya Z, Yuksel S, Ciftci IH, Demirturk N, et al. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B]. Mikrobiyol Bul. 2007;41(2):227-233.
6. Jain P, Nijhawan S. Occult hepatitis C virus infection is more common than hepatitis B infection in maintenance hemodialysis patients. World J Gastroenterol. 2008;14(14):2288-2289.
7. Minuk GY, Sun DF, Greenberg R, Zhang M, Hawkins K, Uhanova J, et al. Occult hepatitis B virus infection in a North American adult hemodialysis patient population. Hepatology. 2004;40(5):1072-1077.
8. Yakaryilmaz F, Gurbuz OA, Guliter S, Mert A, Songur Y, Karakan T, et al. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients. Ren Fail. 2006;28(8):729-735.
9. Lok AS, Lai CL, Wu PC. Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs. Hepatology. 1988;8(4):766-770.
10. Koh HJ, Kim SD, Choi JH, Kim SR, Lee JS. [A study of immune response to hepatitis B vaccine & HBV DNA in isolated anti-HBc positive subjects]. J Prev Med Public Health. 2005;38(2):170-174.
11. Ural O, Findik D. The response of isolated anti-HBc positive subjects to recombinant hepatitis B vaccine. J Infect. 2001;43(3):187-190.
12. Zuckerman JN, Zuckerman AJ. Current topics in hepatitis B. J Infect. 2000;41(2):130-136.
13. Chan CY, Lee SD, Tsai YT, Lo KJ. Hepatitis B vaccination alone is not adequate for the categorizing of adult subjects with isolated anti-HBc. J Gastroenterol Hepatol. 1995;10(2):192-197.
14. Coz Yataco A, Lozano Miranda A, Samalvides Cuba F, Antunez de Mayolo Ramis E. [Significance of the isolated anti-HBc serological pattern determinated by the serological response to the vaccination against Hepatitis B]. Rev Gastroenterol Peru. 2005;25(3):254-258.
15. Draelos M, Morgan T, Schifman RB, Sampliner RE. Significance of isolated antibody to hepatitis B core antigen determined by immune response to hepatitis B vaccination. JAMA. 1987;258(9):1193-1195.
16. Sunbul M, Leblebicioglu H, Esen S, Eroglu C, Barut S. Response to hepatitis B vaccine in HBsAg/anti-HBs negative and anti-HBc positive subjects. Scand J Infect Dis. 2000;32(3):315-316.
17. Tseng KC, Lei HY, Cheng PN, Young KC, Jen CM, Wu CH, et al. Immune response to hepatitis B vaccine of subjects with isolated antibody to hepatitis B core antigen. Hepatogastroenterology. 2003;50(53):1474-1477.
18. Lai CL, Lau JY, Yeoh EK, Chang WK, Lin HJ. Significance of isolated anti-HBc seropositivity by ELISA: implications and the role of radioimmunoassay. J Med Virol. 1992;36(3):180-183.
19. Kabir A, Keshvari M, Kashani AH, Alavian SM. Predicting response to HBV vaccination in people with positive anti-HBc but negative HBsAg and anti-HBs. Hum Vaccin. 2008;4(5):379-383.